Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aquabiotics is a biotechnology company specializing in the development and commercialization of advanced microbial solutions for the aquaculture industry. The company focuses on creating proprietary probiotic consortia designed to enhance the health and productivity of aquatic species, particularly shrimp and finfish, by stabilizing gut microbiota and improving water quality. Their products serve as sustainable alternatives to traditional antibiotics, addressing the growing global demand for antibiotic-free seafood production. Aquabiotics leverages deep expertise in microbiology and aquatic ecology to provide scalable solutions that mitigate disease outbreaks and optimize growth rates in commercial aquaculture operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aquabiotics.